10-KPeriod: FY2005

INTUITIVE SURGICAL INC Annual Report, Year Ended Dec 31, 2005

Filed March 15, 2006For Securities:ISRG

Summary

Intuitive Surgical Inc. demonstrated significant growth in 2005, with sales increasing by 64% to $227.3 million, driven by the expanding adoption of its da Vinci Surgical System. The company saw strong performance across multiple surgical specialties, particularly in urology, and noted a substantial increase in recurring revenue from instruments, accessories, and service, which constituted 45% of total sales. Key strategic achievements included expanding FDA clearances for broader urologic and gynecologic procedures, and the successful market penetration in the radical prostatectomy segment, capturing approximately 20% of the U.S. market by year-end. Financially, Intuitive Surgical reported a substantial increase in operating income to $68.8 million, a 225% jump from the previous year, and improved gross profit margins to 68%. The company also strengthened its financial position with a significant increase in cash, cash equivalents, and investments, ending the year with over $200 million. Significant investments were made in expanding facilities to support future growth, including the acquisition of a new campus. The company launched the da Vinci S Surgical System in early 2006, signaling continued innovation and a commitment to enhancing its product line.

Key Highlights

  • 1Sales grew by 64% to $227.3 million in 2005, demonstrating strong market adoption of the da Vinci Surgical System.
  • 2Recurring revenue (instruments, accessories, service, training) increased by 71% to $102.7 million, representing 45% of total sales, indicating a growing services-based revenue stream.
  • 3The company captured approximately 20% market share in U.S. radical prostatectomy procedures by year-end 2005, a significant increase from previous years.
  • 4Operating income more than tripled, growing 225% to $68.8 million, highlighting improved operational leverage and profitability.
  • 5Gross profit margin improved significantly to 68% from 63% in 2004, driven by increased sales volume and operational efficiencies.
  • 6The company received expanded FDA clearances for urologic and gynecologic surgical procedures in 2005.
  • 7Intuitive Surgical launched the new da Vinci S Surgical System in January 2006, indicating ongoing product development and market expansion efforts.

Frequently Asked Questions

Intuitive Surgical designs, manufactures, and markets the da Vinci Surgical System, an advanced robotic surgical system that enables surgeons to perform minimally invasive surgery with enhanced precision, control, and visualization. The system consists of a surgeon's console, a patient-side cart, a vision system, and proprietary instruments.

The company generates revenue from two primary sources: initial capital sales of the da Vinci Surgical System (which sells for approximately $1 million or more) and recurring revenue from the sale of instruments, accessories, service contracts, and training. Recurring revenue has been growing at a faster rate than capital sales and is becoming an increasingly significant portion of total revenue.

In 2005, Intuitive Surgical experienced substantial growth, with total sales reaching $227.3 million (up 64% from 2004). Operating income surged by 225% to $68.8 million, and gross profit margin improved to 68%. The company also ended the year with a strong cash position of over $200 million.

Key risks include the need for market acceptance of the da Vinci Surgical System, intense competition from existing and emerging surgical techniques, long and variable sales cycles, challenges in international operations, potential product defects and liability claims, manufacturing issues, reliance on sole-source suppliers, and uncertainty regarding third-party reimbursement for procedures using their products.